MariMed Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	2018 - 2011
Net Income	-16.68	-16.03	13.47	7.23	2.14	-66.52	Upgrade
Depreciation & Amortization	9.34	8.57	4.71	2.79	2.18	1.2	Upgrade
Share-Based Compensation	1.06	1.02	6.34	13.44	0.99	0.22	Upgrade
Other Operating Activities	21.9	14.35	-17.21	12.4	-1.94	40.96	Upgrade
Operating Cash Flow	15.62	7.91	7.31	35.85	3.38	-24.14	Upgrade
Operating Cash Flow Growth	-	8.19%	-79.61%	960.70%	-	-	Upgrade
Capital Expenditures	-20.74	-20.76	-12.74	-18.57	-4.94	-9.98	Upgrade
Acquisitions	-1.33	-4.11	-13.65	-0.01	-0.26	-0.21	Upgrade
Change in Investments	-0.35	-2.87	-	-2.17	-	-5.36	Upgrade
Other Investing Activities	-0.92	1.75	0.14	4.12	0.73	3.01	Upgrade
Investing Cash Flow	-23.33	-25.99	-26.24	-16.62	-4.46	-12.54	Upgrade
Dividends Paid	-0.17	-0.16	-0.26	-0.41	-0.31	-0.47	Upgrade
Common Stock Issued	-2.46	0.11	0.01	23	0.08	3.46	Upgrade
Share Repurchases	-2.59	0.3	0.3	-23	0	0	Upgrade
Other Financing Activities	1.39	23.33	-0.46	-38.14	3.58	30.32	Upgrade
Financing Cash Flow	1.35	22.98	-1.01	7.45	3.34	33.31	Upgrade
Net Cash Flow	-6.36	4.91	-19.95	26.68	2.26	-3.37	Upgrade
Free Cash Flow	-5.12	-12.85	-5.43	17.29	-1.56	-34.12	Upgrade
Free Cash Flow Margin	-3.36%	-8.64%	-4.05%	14.23%	-3.07%	-74.81%	Upgrade
Free Cash Flow Per Share	-0.01	-0.04	-0.01	0.05	-0.00	-0.16	Upgrade

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.